Beyond the exome: the role of non-coding somatic mutations in cancer.

Abstract excerpt

The comprehensive identification of mutations contributing to the development of cancer is a priority of large cancer sequencing projects. To date, most studies have scrutinized mutations in coding regions of the genome, but several recent discoveries, including the identification of recurrent somatic mutations in the TERT promoter in multiple cancer types, support the idea that mutations in non-coding regions...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Exome
• Share to Genome, Human
• Share to High-Throughput Nucleotide Sequencing